Stay updated on BOS-580 in NASH Obese Subjects Clinical Trial
Sign up to get notified when there's something new on the BOS-580 in NASH Obese Subjects Clinical Trial page.
Latest updates to the BOS-580 in NASH Obese Subjects Clinical Trial page
- Check5 days agoChange DetectedThe study has transitioned from BOS-580 to Efimosfermin, with updated dosing cohorts and a focus on safety, tolerability, and pharmacokinetics in obese participants with NASH.SummaryDifference22%
- Check12 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedA new study has been added with 48 participants and an actual status as of November 18, 2024, while several previously listed studies have been removed, including those that were withdrawn or not yet recruiting across various locations.SummaryDifference11%
- Check48 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources related to genetics and rare diseases, while the previous version 2.12.1 has been removed.SummaryDifference4%
- Check55 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
Stay in the know with updates to BOS-580 in NASH Obese Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BOS-580 in NASH Obese Subjects Clinical Trial page.